Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma

التفاصيل البيبلوغرافية
العنوان: Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma
المؤلفون: Yu Xie, Shusuan Jiang, Chun-He Yang, Weiqing Han, Jian Cao, Zhizhong Liu
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
بيانات النشر: Frontiers Media SA, 2021.
سنة النشر: 2021
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Cancer Research, Malignancy, Somatic evolution in cancer, 03 medical and health sciences, 0302 clinical medicine, patient survival, CDKN2A, Internal medicine, medicine, whole-exome sequencing, Lymph node, RC254-282, Original Research, lymph node metastasis, business.industry, Standard treatment, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cell cycle, medicine.disease, 030104 developmental biology, medicine.anatomical_structure, Tumor progression, 030220 oncology & carcinogenesis, penile squamous cell carcinoma, business, somatic alteration
الوصف: Penile squamous cell carcinoma (PSCC) is a rare malignancy with poor survival after standard treatment. Although genomic alterations of PSCC have been characterized in several latest studies, the association between the formation of somatic landscape and regional lymph node metastasis (LNM), an important predictor for patient survival, has not been comprehensively investigated. Here, we collected formalin-fixed paraffin-embedded tumor tissue and matched normal samples of 32 PSCC patients, including 14 LNM patients and 18 clinically node-negative patients, to implement a whole-exome sequencing. Comparison of genomic features among different lymph node status subgroups was conducted after genomic profiling and its effects on patient survival were explored. Top-ranked recurrent gene mutants in our PSCC cohort were TP53 (13/32), NOTCH1 (12/32), CDKN2A (11/32), TTN (9/32) and FAT1 (8/32), mainly identified in the Notch, Hippo, cell cycle, TP53, RTK-RAS and PI3K pathways. While CDKN2A was confirmed to be the driver gene in all PSCC patients, certain gene mutants were significantly enriched in LNM involved patients, including TP53 (9/14 vs. 4/18, p = 0.029) and GBF1 (4/14 vs. 0/18, p = 0.028). Overall survival stratification of PSCC patients were found to be significantly correlated with mutations of three genes, including PIK3CA (Hazard ratio [HR] = 4.15, p = 0.029), CHD7 (HR = 4.82, p = 0.032) and LAMC3 (HR = 15.9, p < 0.001). PIK3CA and LAMC3 held a higher prevalence in patients with LNM compared to those without LNM (PIK3CA: 3/14 vs. 1/18, LAMC3: 2/14 vs. 1/18). Our finding demonstrated that genomic divergence exists across PSCC patients with different lymph node statuses, and it may be correlated with their survival outcome. It helps delineate somatic evolution during tumor progression and perfect potential therapeutic intervention in this disease.
اللغة: English
تدمد: 2234-943X
DOI: 10.3389/fonc.2021.641869
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80cf00a2984fa14da3de813872eab5a6
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....80cf00a2984fa14da3de813872eab5a6
قاعدة البيانات: OpenAIRE
الوصف
تدمد:2234943X
DOI:10.3389/fonc.2021.641869